Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.3B | 2.9B | 2.8B | 2.7B |
Cost of revenue | 1.0B | 790M | 737M | 713M |
Gross profit | 2.3B | 2.2B | 2.0B | 2.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 830M | 795M | 740M | 739M |
Operating income | 953M | 864M | 814M | 738M |
Non operating interest income | ||||
Income | 12M | 15M | 17M | 16M |
Expense | 370M | 368M | 355M | 347M |
Other income expense | 79M | 33M | 85M | 49M |
Pretax income | 674M | 544M | 561M | 456M |
Tax provision | 116M | 93M | 83M | 69M |
Net income | 558M | 451M | 478M | 387M |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 1.5B | 1.5B | 1.3B | 1.3B |
Net income from continuing op. | 558M | 451M | 478M | 387M |
Minority interests | -38M | -36M | -39M | -38M |
Preferred stock dividends | — | — | — | — |